CatallaxCore
← Back to bills

SB 23-041

signed

Prescription Drugs For Off-label Use

Plain-English Summary

AI-generated

Senate Bill 23-041, also known as the Prescription Drugs for Off-label Use bill, allows doctors and other healthcare professionals to prescribe FDA-approved medications for uses that are not officially approved by the FDA, but have been commonly used and supported by medical evidence. This means patients can receive treatments that aren't listed on the drug's official label if their doctor believes it is safe and effective. The bill also protects both prescribers and pharmacists from disciplinary action as long as they provide informed consent to the patient or their guardian. The bill has been signed into law, meaning healthcare providers in Colorado are now legally allowed to prescribe drugs for off-label use under certain conditions, without fear of punishment if they follow these guidelines.

Official Summary

The bill authorizes a physician, a physician assistant, and an advanced practice registered nurse licensed health-care professional who is authorized to prescribe drugs (prescriber) to prescribe and administer a drug approved by the federal food and drug administration (FDA) for an off-label use. if: The off-label use of the drug for the indication has longstanding, common use; There is medical evidence to support the off-label use and no known evidence contraindicating such off-label use; and The prescriber has provided the patient or a minor patient's parent or guardian with an informed consent form, and the patient or parent or guardian has signed the form. The bill applies the same standard of care for the off-label use of the drug as for the on-label use of the drug. The bill clarifies that: The prescription and administration of an FDA-approved drug for an off-label use is not, by itself, a grounds for discipline; and A pharmacist who fills a prescription for off-label use is not subject to discipline by the state board of pharmacy. (Note: Italicized words indicate new material added to the original summary; dashes through words indicate deletions from the original summary.) (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Details

Chamber
Senate
First action
2023-03-21
Latest action
2023-01-12
Last action desc.
Introduced In Senate - Assigned to Health & Human Services
OpenStates
View source ↗

Sponsors

Related Legislation

This bill affects (7)

relates
HB 23-1097(2023A)· signed
Painkiller Administration Prior To Abortion
relates
HB 22-1115(2022A)· signed
Prescription Drug Monitoring Program
relates
HB 23-1071(2023A)· signed
Licensed Psychologist Prescriptive Authority
relates
HB 17-1240(2017A)· signed
Relocate Title 12 Colorado Department Of Public Health And Environment
relates
SB 22-027(2022A)· signed
Prescription Drug Monitoring Program
relates
HB 22-1235(2022A)· signed
Sunset Continue Regulation Of Veterinary Practice
relates
SB 23-009(2023A)· signed
Limit Opioid Prescription And Exception For Intractable Pain

Affected by (12)

amends
HB 25-1285(2025A)· signed
Veterinary Workforce Requirements
amends
HB 26-1198(2026A)· signed
Access to Veterinary Care
amends
SB 23-167(2023A)· signed
Board Of Nursing Regulate Certified Midwives
relates
HB 23-1077(2023A)· signed
Informed Consent To Intimate Patient Examinations
relates
HB 24-1048(2024A)· signed
Providing Veterinary Services Through Telehealth
relates
HB 23-1195(2023A)· signed
Automated Pharmacy Dispensing System
relates
HB 23-1256(2023A)· signed
Health-care Professional Telehealth Out-of-state Patient
relates
SB 23-190(2023A)· signed
Deceptive Trade Practice Pregnancy-related Service
relates
SB 23-188(2023A)· signed
Protections For Accessing Reproductive Health Care
relates
SB 25-159(2025A)· signed
Use of Veterinary Telehealth
repeals
HB 26-1182(2026A)· signed
Sunset Veterinary Pharmaceutical Advisory Committee
repeals
SB 24-047(2024A)· signed
Prevention of Substance Use Disorders

Votes

BILL
2023-02-08 · Senate · passYes: 33 · No: 0 · Other: